		Technical Data
C1035-29Y1	CAPN9, NT (Calpain-9, Digestive Tract-specific Calpain, New Calpain 4, nCL-4, Protein CG36, NCL4)

Description:
CAPN9 has been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein is expressed predominantly in stomach and small intestine and may have specialized functions in the digestive tract. This protein is thought to be associated with gastric cancer.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:50-1:100
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Type	Isotype	Clone	Grade
Pab	IgG		Purified

Size		Storage	Shipping	Source	Host
200ul		-20°C	Blue Ice	Human	Rabbit

Concentration:

~0.25mg/ml

Immunogen:

Synthetic peptide selected from the N-terminal region of human CAPN9 (KLH).

Purity:

Purified by ammonium sulfate precipitation.

Form

Supplied as a liquid in PBS, 0.09% sodium azide.

Specificity:

Recognizes human CAPN9.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

1.Huang,Y. and Wang,K.K. Trends Mol Med 7(8), 355-362 (2001). 2.Lee,H.J., Tomioka,S. Arch. Biochem. Biophys. 362(1), 22-31 (1999). 3.Lee,H.J., Sorimachi,H. Biol. Chem. 379(2), 175-183 (1998). 4.Suzuki,K., Sorimachi,H. Biol. Chem. Hoppe-Seyler 376(9), 523-529 (1995).